Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung CancerKoichi Takayama, Yoichi Nakanishi, Taishi Harada et al.|Journal of Immunology Research|2016Cited by 25
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung CancerShinjiro Sakamoto, Tetsuro Sasada, Teppei Yamada et al.|Clinical Lung Cancer|2017Cited by 15
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patientsShigetaka Suekane, Masanori Noguchi, Shigeru Yutani et al.|International Journal of Oncology|2020Cited by 6